1. Home
  2. ABOS vs INTT Comparison

ABOS vs INTT Comparison

Compare ABOS & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • INTT
  • Stock Information
  • Founded
  • ABOS 1996
  • INTT 1981
  • Country
  • ABOS United States
  • INTT United States
  • Employees
  • ABOS N/A
  • INTT N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • ABOS Health Care
  • INTT Technology
  • Exchange
  • ABOS Nasdaq
  • INTT Nasdaq
  • Market Cap
  • ABOS 76.9M
  • INTT 77.3M
  • IPO Year
  • ABOS 2021
  • INTT 1997
  • Fundamental
  • Price
  • ABOS $1.02
  • INTT $6.11
  • Analyst Decision
  • ABOS Strong Buy
  • INTT Strong Buy
  • Analyst Count
  • ABOS 3
  • INTT 2
  • Target Price
  • ABOS $7.33
  • INTT $16.00
  • AVG Volume (30 Days)
  • ABOS 268.2K
  • INTT 42.4K
  • Earning Date
  • ABOS 05-13-2025
  • INTT 05-02-2025
  • Dividend Yield
  • ABOS N/A
  • INTT N/A
  • EPS Growth
  • ABOS N/A
  • INTT N/A
  • EPS
  • ABOS N/A
  • INTT 0.24
  • Revenue
  • ABOS N/A
  • INTT $130,690,000.00
  • Revenue This Year
  • ABOS N/A
  • INTT $6.67
  • Revenue Next Year
  • ABOS N/A
  • INTT $6.66
  • P/E Ratio
  • ABOS N/A
  • INTT $25.64
  • Revenue Growth
  • ABOS N/A
  • INTT 5.99
  • 52 Week Low
  • ABOS $0.86
  • INTT $5.24
  • 52 Week High
  • ABOS $3.92
  • INTT $12.02
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 45.08
  • INTT 39.05
  • Support Level
  • ABOS $0.86
  • INTT $5.93
  • Resistance Level
  • ABOS $1.13
  • INTT $6.15
  • Average True Range (ATR)
  • ABOS 0.13
  • INTT 0.41
  • MACD
  • ABOS 0.01
  • INTT 0.05
  • Stochastic Oscillator
  • ABOS 52.38
  • INTT 63.97

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: